Evidence map›Paper›PMID 41420215›Full record

ArticleInternational journal of emergency medicine2025

Clinical and toxicological epidemiology of intoxications by new psychoactive substances in Reunion Island.

Adrien Maillot, Joris Guyon, Maeva Ma-Tsi-Leong, Laetitia Berly, Flore Weisse, Aurore Mahé, Gael Le Roux, Frédérique Nativel, Amélie Daveluy, Bérénice Puech and 6 more

Abstract read
In one paragraph

Article in International journal of emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Adrien MaillotINSERM CIC 1410, Centre Hospitalier Universitaire de La Réunion, Allée des Topazes, Saint-Denis, Ile de La Réunion, 97400, France. adrien.maillot@chu-reunion.fr.
Joris GuyonDepartment of Medical Pharmacology, CHU Bordeaux, Bordeaux, France.
Maeva Ma-Tsi-LeongClinical Investigation Center, INSERM CIC1410, Centre Hospitalier Universitaire de La Réunion, Saint-Pierre, Réunion, France.
Laetitia BerlyDirection of Clinical Research and Innovation (DRCI), Centre Hospitalier Universitaire de La Réunion, Saint-Denis, Réunion, France.
Flore WeisseEmergency Department, University Hospital of la Reunion, Saint-Denis, France.
Aurore MahéEmergency Department, Centre Hospitalier Ouest Réunion, Saint-Paul, France.
Gael Le RouxWestern Poison Control Center, University Hospital, 4 Rue Larrey, Angers, 49100, France.
Frédérique NativelEmergency Department, SAMU, University Hospital of La Reunion, Saint-Denis, Réunion, France.
Amélie DaveluyService de Pharmacologie Médicale, CEIP-A Bordeaux-DROM, CHU Bordeaux, Univ. Bordeaux, Inserm, BPH, U1219, Bordeaux, France.
Bérénice PuechIntensive Care Unit, University Hospital of La Reunion, Saint-Denis, Réunion, France.
Adrien MarteauEmergency Department, University Hospital of La Reunion, Saint-Pierre, France.
Marion LeroyInstitut de Médecine Légale, CHU de La Réunion, Allée des Topazes, Saint- Denis, 97400, France.
Olivia PléInstitut de Médecine Légale, CHU de La Réunion, Allée des Topazes, Saint- Denis, 97400, France.
Olivier MaillardClinical Investigation Center, INSERM CIC1410, Centre Hospitalier Universitaire de La Réunion, Saint-Pierre, Réunion, France.
Sophie BastardBiochemistry Laboratory, University Hospital of La Reunion, Saint-Denis, France.
David MeteAddictology Department, University Hospital of La Reunion, Saint-Denis, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNew psychoactive substances (NPS) represent a growing concern for emergency medicine due to their unpredictable toxicity and limited detectability in routine screening. Reunion Island, French territories in the Indian Ocean, NPS-related intoxications have been suspected for several years, but biological confirmation has remained scarce. This study aimed to characterise confirmed cases of acute NPS intoxication and describe their clinical features, toxicological profiles, and implications for emergency care and public health surveillance.

methodsA retrospective multicentre study was conducted in four public hospitals of Reunion Island between August 2022 and March 2024. Patients presenting with suspected NPS intoxication were mainly identified in emergency and intensive care units. Biological samples were analysed using untargeted high-resolution mass spectrometry (HRMS). Clinical, demographic, and toxicological data were extracted from medical records through a standardised electronic case report form. Confirmed NPS were grouped by pharmacological class, and their clinical manifestations were compared with non-NPS cases.

resultsAmong 176 suspected cases, 152 (86%) had biological analyses performed. The median age was 29 years, and 77% were men. Most exposures were intentional (77.3%), but unintentional cases—more frequent among women—were also reported. Fourteen intoxications were biologically confirmed, involving synthetic cathinones (dimethylpentylone, hexedrone), cannabinoids (MDMB-4en-PINACA, HHC), a novel opioid (protonitazene), and NM-2AI. Clinical severity ranged from agitation and sedation to cardiovascular collapse, rhabdomyolysis, and respiratory failure. Inhalation was the predominant route of exposure. Alcohol co-exposure was less common in confirmed NPS cases than in conventional drug intoxications.

conclusionThis first series of toxicologically confirmed NPS intoxications on Reunion Island highlights the clinical diversity and potential severity of these emerging substances. For emergency departments, early recognition of unexplained toxidromes, systematic biological sampling, and close collaboration with toxicology laboratories are essential. Strengthened analytical capacity and coordinated toxicovigilance networks are urgently needed to improve detection, guide patient management, and anticipate emerging psychoactive threats.

Indexed as

Drug-checkingNovel synthetic opioidsNPSSynthetic cannabinoid receptor agonistsSynthetic cathinonesToxicology

Identifiers

PMID41420215
PMCPMC12717732

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.